Status:

UNKNOWN

Sufficient Treatment of Peripheral Intervention by Cilostazol

Lead Sponsor:

Kansai Rosai Hospital

Collaborating Sponsors:

Association for Establishment of Ebvidence in Interventions

Conditions:

Arteriosclerosis Obliterans

Eligibility:

All Genders

20+ years

Phase:

PHASE4

Brief Summary

Recently, Nanto et al. reported that cilostazol effectively prevented restenosis in a retrospective analysis of 121 femoropopliteal artery lesions in percutaneous transluminal angioplasty (PTA) patien...

Eligibility Criteria

Inclusion

  • Patient criteria:
  • Chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area\*
  • Patients who can be monitored for at least 2 years after surgery
  • Lesion criteria:
  • Angiographically-confirmed new significant superficial femoral artery stenosis or occlusive lesions that are 30 cm long or less if stented
  • At least 1 arterial runoff below the knee; stenosis lesions not limiting flow may be included.
  • Occlusive lesions may be included.
  • Exclusion criteria:
  • Patients with or at risk of hemorrhagic complications or patients with bleeding tendency
  • Patients with congestive cardiac failure
  • Patients with a drug-eluting stent
  • Patients with acute lower limb ischemia
  • Patients with creatinine of 2 mg/dL or more(without dialysis)
  • patients with a history of serious adverse reaction such as leukopenia, hepatic dysfunction, or renal dysfunction, or hypersensitivity to any component of the study drug.
  • Lesion criteria:
  • Remnant inflow
  • Severe calcification
  • No arterial runoff below the knee

Exclusion

    Key Trial Info

    Start Date :

    March 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2012

    Estimated Enrollment :

    200 Patients enrolled

    Trial Details

    Trial ID

    NCT00912756

    Start Date

    March 1 2009

    End Date

    September 1 2012

    Last Update

    July 22 2010

    Active Locations (13)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 4 (13 locations)

    1

    Shinkoga Hospital

    Kurume, Fukuoka, Japan, 8308577

    2

    Hyogo College of Medicine Hopital

    Nishinomiya, Hyōgo, Japan, 663-8501

    3

    Department of Cardiology, Kanazawa Cardiovascular Hospital

    Kanazawa, Ishikawa-ken, Japan, 920-0007

    4

    Department of Cardiology,Naganoken Koseiren Shinonoi

    Nagano, Nagano, Japan, 3888004